about
Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cellsHIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development.c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells.P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors.An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challengeCopper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity.Altered miRNA expression in T regulatory cells in course of multiple sclerosis.The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.Problems and emerging approaches in HIV/AIDS vaccine development.Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice.UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule SecretionStudies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors.Lysis-on-chip of single target cells following forced interaction with CTLs or NK cells on a dielectrophoresis-based array.Novel oleanolic vinyl boronates: synthesis and antitumor activity.Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.Synthesis and biological evaluation of diastereoisomerically pure N,O-nucleosides.Alpha,beta-unsaturated N-acylpyrrole peptidyl derivatives: new proteasome inhibitors.Effects of biomaterials for Lab-on-a-chip production on cell growth and expression of differentiated functions of leukemic cell lines.Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope.N-terminal-prolonged vinyl ester-based peptides as selective proteasome beta1 subunit inhibitors.New cyclic peptide proteasome inhibitors.Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors.Phosphinic platinum complexes with 8-thiotheophylline derivatives: synthesis, characterization, and antiproliferative activity.Down-regulation of proteolytic complexes following EBV activation in BL cells.Peptidyl vinyl ester derivatives: new class of selective inhibitors of proteasome trypsin-like activity.T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120.Biologically active platinum complexes containing 8-thiotheophylline and 8-(methylthio)theophylline.Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors.Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8.Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection.Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.Peptide analogues of a subdominant epitope expressed in ebv-associated tumors: synthesis and immunological activity.Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope.Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies.High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes.Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides.IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils.Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes.
P50
Q28476783-6D20D5A4-4982-45F0-A9E5-82D6AC3F4330Q30381447-C1521012-90B6-4E23-82C9-295D1982BE1AQ32084062-F86D2D6C-178B-4CFC-9256-1BDF87DC86E6Q33239334-E7AAAEB4-D802-431C-AE51-3415B782F10AQ33916162-B3233556-6C63-4DC4-9720-FE57FDD46227Q33944399-ED2F7EE7-A836-4204-B13B-C35707776072Q34126437-D5DA8AF0-EAA9-47CA-B519-2F31924F90B6Q35040673-732E7C4F-0E7E-42B8-BBE2-68649E37D1FCQ36758574-9886BA03-BE28-4DE3-9FA0-B769B2ABFBA3Q36786660-43686B87-96AA-4D69-BB34-30390A06101AQ37536040-C5C9B844-936E-4165-B849-388B19E542BEQ38878928-1AB618EA-A045-4A41-8A31-2B61A1DA4F0DQ39100054-3D9A0A8D-E4F3-4557-8CE1-134AD8E8783CQ39186234-914CB52E-2ECF-4C43-A46D-CD824F5142E1Q39588027-CFECCEAF-B275-4261-8D65-FFA2E3AA3A42Q39629519-623C7149-FBBC-4034-B319-4A83AA464F9EQ39660130-509229DA-838C-4895-A507-905EA1D31C7EQ39670838-ACAA4BC1-B049-41C5-9D6E-63AC28FF5025Q39681040-AFFAFE84-0BA2-443D-856F-23FABC2933F2Q39773325-3C26C676-F94F-4340-96B4-FD04734E0010Q39829258-AA30BE00-E3DD-457E-81D0-350B7119BB6DQ39878614-EE188C28-E884-4944-87A9-98E61E966C71Q39919119-9797D35F-64E6-4074-9088-5C12E4EE530AQ40053280-735C92A6-CE80-4694-B7CE-82B177BFC822Q40143810-7CAEDC69-FEFE-4FF5-A843-F4FDCEC3B3D9Q40198707-ED9902D7-4892-47C8-965E-2BCEFD43F16AQ40395471-4EC32E2F-93D0-4AEC-A3F7-4BDF2FE64F49Q40501551-38073D4C-8EFC-4183-A7C8-AADBF72FEEB3Q40593880-C31C8349-D2A2-48AE-8C5D-867D09E40C72Q40703241-778A55E3-3F32-48CF-BCE0-BB4297942CA1Q40720422-D05C4A6F-A48E-4212-B236-2714711C9979Q40745814-91437AFD-BE11-4AA4-B2E4-AD7C32B734FEQ40761226-62A4E617-086E-4060-BF91-9D3E30636145Q40796120-4F1285B9-283E-490B-BD77-502DF5573093Q40866976-19D15EB0-1589-4D86-9969-1BB993BD341FQ40933846-BBF202AC-96B6-4F8D-866C-501D29146F01Q41064733-3B48F313-E35F-477A-86D4-76F62C8AA6CAQ41182122-4B076CF8-E7E3-4E9A-AA41-37AAA39B86A6Q41341349-18EDD5CF-ACCA-40DB-892D-E55CF6DD51DCQ41381781-96AEE9A6-D026-4A7A-AA5B-F8A30334AE9E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Riccardo Gavioli
@ast
Riccardo Gavioli
@en
Riccardo Gavioli
@es
Riccardo Gavioli
@nl
Riccardo Gavioli
@sl
type
label
Riccardo Gavioli
@ast
Riccardo Gavioli
@en
Riccardo Gavioli
@es
Riccardo Gavioli
@nl
Riccardo Gavioli
@sl
prefLabel
Riccardo Gavioli
@ast
Riccardo Gavioli
@en
Riccardo Gavioli
@es
Riccardo Gavioli
@nl
Riccardo Gavioli
@sl
P1053
K-7594-2016
P106
P21
P31
P3829
P496
0000-0002-7805-4290